The United Laboratories International Holdings Limited (ULIHF)

OTCMKTS · Delayed Price · Currency is USD
1.330
0.00 (0.00%)
Mar 26, 2026, 4:00 PM EST
Market Cap2.56B -24.7%
Revenue (ttm)1.89B -4.0%
Net Income298.22M -21.6%
EPS0.16 -24.4%
Shares Outn/a
PE Ratio8.57
Forward PE11.00
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume5,887
Open1.330
Previous Close1.330
Day's Range1.330 - 1.330
52-Week Range1.330 - 2.277
Beta0.14
RSI46.27
Earnings DateMar 24, 2026

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin... [Read more]

Sector Healthcare
Founded 1990
Employees 17,400
Stock Exchange OTCMKTS
Ticker Symbol ULIHF

Financial Performance

In 2025, ULIHF's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY Financial Statements